Skip to main content
. 2016 Feb 18;6(2):115–124. doi: 10.1016/j.apsb.2016.01.008

Table 4.

The structure, physico-chemical properties, and antimalarial activitya of compounds 3946.

graphic file with name fx4.gif











Compd. Solubility (mg/L) logP n-octanol/buffer P. berghei ED90 (mg/kg)
P. berghei artesunate indexb
P. yoelii ED90 (mg/kg)
P. yoelii artesunate index
sc po sc po sc po sc
Artesunate 565 2.77 7.2 7.1 1.0 1.0 22.0 -- 1.0
39 8 5.62 0.8 3.5 9.0 2.0 0.85 3.0 25.9
40 < 2 4.78 0.6 2.8 12 2.5 0.52 2.0 42.3
41 89 2.49 1.5 3.1 4.8 2.3 3.9 5.0 5.6
42 < 1 5.59 1.16 5.0 6.2 1.4 1.08 -- 20.4
43 < 1 6.15 3.8 4.6 1.9 1.7 3.0 -- 7.3



Artesunatec 565 2.77 4.6 9.3 1.0 1.0 42.0 -- 1.0
44 28.4 3.05 0.18 1.3 25.6 7.15 1.25 1.84 33.6
45 < 2 4.97 0.51 1.9 9.0 4.9 0.61 2.0 81.0



Artesunatec 565 2.77 12.0 -- 1.0 -- 50.0 -- 1.0
46 1251 2.63 9.0 -- 1.3 -- 10.0 -- 5.0



Artemisinin 63 2.94 -- -- -- -- -- -- --
Artemether 117 3.98 -- -- -- -- -- -- --

a

In vivo screens against CQ-sensitive P. berghei N strain and CQ-resistant P. yoelii NS strain. Peters׳ four-day test with mice treated daily subcutaneously (sc) or orally (po) from the day of infection (Day 0) through Day 3; results (ED90 values) were based on parasite counts in peripheral blood on day 4.

b

ED90 (artesunate) / ED90 (tested compound).

c

The variation in artesunate activity in different experiments.